IPLEXMED

IPLEXMED has been selected as one of the finalists in the 2024 edition of the 929 Challenge. This competition connects startups and universities from Portuguese-speaking countries and China, with a focus on promoting sustainable and innovative business projects. As a finalist, IPLEXMED will have the opportunity to present its healthcare solution, NEXAGUARD, engage with industry experts, and explore international market opportunities through this prestigious platform. For more information on the 929 Challenge, visit the official website.

This week, we’ve had inspiring discussions around innovation, collaboration, and building connections at the #IHTConference2024 organized by Health Cluster Portugal. IPLEXMED proudly presented how #Nexaguard is set to drive advancements in value-based healthcare, paving the way for the future of patient care. A heartfelt thank you to all the speakers, participants, and innovators who made this event a remarkable success. Together, we are forging strong partnerships and making a tangible impact on healthcare across Europe and internationally. #MedTech #InnovatingHealthTogether #HealthPortugal #IHTConference2024

IPLEXMED has been selected as one of the Top 100 startups for Slush 2024 out of an incredible 962 applications! 🌟 Slush, held annually in Helsinki, Finland, is one of the world’s most prestigious startup and tech events, connecting innovative founders with top investors like General Catalyst and Cherry Ventures. We couldn’t be more excited to showcase our work. Thank you to Slush for this incredible opportunity! 👏 #startup #innovation #Slush2024 #IPLEXMED #tech #entrepreneurship #healthtech #decentralizeddiagnostics #graphenetech #top100

In the latest episode of the EmpoWomen podcast, Neide Vieira shares insights into the development of our diagnostic platform, NEXAGUARD®, and the relevance of a multidisciplinary team in its creation. Neide also discusses the influence of the EmpoWomen Programme on supporting women entrepreneurs in tech and biotech. Listen to gain a deeper understanding of our journey and the future of healthcare innovation.

IPLEXMED was selected for the inaugural EmpoWomen Program cohort, an inspiring initiative dedicated to empowering visionary women entrepreneurs. Among the 11 exceptional startups chosen through a rigorous process, IPLEXMED stands at the forefront. EmpoWomen Program represents not just an opportunity but a catalyst for transformative growth, offering a bespoke 6-month acceleration program tailored to our needs. While our focus remains steadfast on advancing R&D endeavors, we understand the invaluable insights gained from collaborative peers, especially in the competitive area of medtech. Keen to learn and implement! #medtech #EmpowerWomen #AccelerationProgram #WomenEntrepreneurs #Innovation #Investment #HorizonEurope #DeepTech #Womenintech

🚀 IPLEXMED's journey to redefine medical diagnosis has been a rollercoaster 🎢, filled with both challenges and significant achievements. Last week, we celebrated one of those achievements that we are extremely proud of. We won the Premios EmprendeXXI - Northern region Award, organized by Banco BPI and CaixaBank's DayOne, which recognizes and supports innovative companies with high growth potential. 🏆 This win is an encouragement for us to continue developing our innovative diagnostic platform, NexaGuard, which will change the way respiratory infections are diagnosed, positively impacting patients and benefiting healthcare providers. 🌍 The Premios EmprendeXXI Award will provide access to international support and mentoring programs, offering invaluable guidance for the growth of IPLEXMED. 🌟 Thank you to the Premios EmprendeXXI Award, Banco BPI, and CaixaBank DayOne for this recognition, and congratulations to all the amazing finalists! 👏 See you in Boston! #IPLEXMED #MedTech #EmprendeXXIAwards #BPI #CaixaBank #Innovation #Entrepreneurship

Thrilled to announce that Neide Vieira, PhD, co-founder of IPLEXMED, has been selected to participate in the prestigious EIC Women in Leadership Programme as part of the #EUeic Business Accelerator Services. This incredible opportunity will enhance our in-house leadership skills and empower us to drive innovation and growth in the healthcare sector. Looking forward to leveraging the tailored training, networking events, and personalized mentorship to propel IPLEXMED to new heights! European Innovation Council and SMEs Executive Agency (EISMEA) Global Impact Hub Female Founders #WomenInLeadership #Innovation #HealthcareTech

Last year was transformative for IPLEXMED, we raised our pre-seed round of investment and overcame numerous challenges. We are pleased to kick off 2024 by being highlighted as one of the most innovative startups in IVD, contributing to shape a new era for In Vitro Diagnostics. #ivd #medtech #innovation